Peter Wark

Peter Alexander Blanch Wark; ORCID: 0000-0001-5676-6126. Peter Wark is the Director of Cystic Fibrosis and RES2, AIRMED, Alfred Health, Melbourne. He is a conjoint Professor of Medicine at Monash University. He holds an honorary position as a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle and is an adjunct Professor with the University of Newcastle and senior affiliate researcher at the Hunter Medical Research Institute (HMRI) Immune Health Research programme at HMRI. His research interests are; airway inflammation in the context of chronic airways disease, innate immunity, the role of infection in chronic airways disease and translational clinical trial design. His group has developed expertise in identifying respiratory viruses in airway secretions and developing an in-vitro cell culture model of the airway epithelium that we use to model the effect of infection and inflammation. His research focuses upon factors that increase susceptibility to virus infection in asthma, COPD, Cystic Fibrosis and bronchiectasis. Characterising airway inflammation and innate immune responses in chronic airways disease and applying this to clinical care, as well as the development of precise individualised management strategies.